BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 9573275)

  • 21. Prolonged poliovirus excretion in an immunodeficient person with vaccine-associated paralytic poliomyelitis.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Jul; 46(28):641-3. PubMed ID: 9233551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The neuropathology observed in wild-type mice inoculated with human poliovirus mirrors human paralytic poliomyelitis.
    Ford DJ; Ropka SL; Collins GH; Jubelt B
    Microb Pathog; 2002 Sep; 33(3):97-107. PubMed ID: 12220986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Injections and poliomyelitis: what are the risks of vaccine associated paralysis?
    Wyatt HV
    Dev Biol Stand; 1986; 65():123-6. PubMed ID: 3549394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retrograde transport of intact poliovirus through the axon via the fast transport system.
    Ohka S; Yang WX; Terada E; Iwasaki K; Nomoto A
    Virology; 1998 Oct; 250(1):67-75. PubMed ID: 9770421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paralytic poliomyelitis associated with Sabin monovalent and bivalent oral polio vaccines in Hungary.
    Estívariz CF; Molnár Z; Venczel L; Kapusinszky B; Zingeser JA; Lipskaya GY; Kew OM; Berencsi G; Csohán A
    Am J Epidemiol; 2011 Aug; 174(3):316-25. PubMed ID: 21685412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis.
    Pliaka V; Kyriakopoulou Z; Markoulatos P
    Expert Rev Vaccines; 2012 May; 11(5):609-28. PubMed ID: 22827246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Innate host barriers to viral trafficking and population diversity: lessons learned from poliovirus.
    Pfeiffer JK
    Adv Virus Res; 2010; 77():85-118. PubMed ID: 20951871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaccine-associated paralytic poliomyelitis in the United States: no evidence of elevated risk after simultaneous intramuscular injections of vaccine.
    Izurieta HS; Sutter RW; Baughman AL; Strebel PM; Stevenson JM; Wharton M
    Pediatr Infect Dis J; 1995 Oct; 14(10):840-6. PubMed ID: 8584308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pathogenesis of poliomyelitis: what we don't know.
    Nathanson N
    Adv Virus Res; 2008; 71():1-50. PubMed ID: 18585526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis.
    Ciapponi A; Bardach A; Rey Ares L; Glujovsky D; Cafferata ML; Cesaroni S; Bhatti A
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011260. PubMed ID: 31801180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular aspects of poliovirus biology with a special focus on the interactions with nerve cells.
    Blondel B; Duncan G; Couderc T; Delpeyroux F; Pavio N; Colbère-Garapin F
    J Neurovirol; 1998 Feb; 4(1):1-26. PubMed ID: 9531008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of provocation poliomyelitis in vaccine-associated poliomyelitis.
    Ehrengut W
    Acta Paediatr Jpn; 1997 Dec; 39(6):658-62. PubMed ID: 9447753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Age-dependent poliovirus replication in the mouse central nervous system is determined by internal ribosome entry site-mediated translation.
    Kauder S; Kan S; Racaniello VR
    J Virol; 2006 Mar; 80(6):2589-95. PubMed ID: 16501069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccinology of poliomyelitis.
    Salk D; Salk J
    Vaccine; 1984 Mar; 2(1):59-74. PubMed ID: 6099644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular pathogenesis of type 2 poliovirus in mice.
    Couderc T; Guinguene B; Horaud F; Aubert-Combiescu A; Crainic R
    Eur J Epidemiol; 1989 Sep; 5(3):270-4. PubMed ID: 2551721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Provocation poliomyelitis and entry of poliovirus to the CNS.
    Wyatt HV
    Med Hypotheses; 1976; 2(6):269-74. PubMed ID: 187911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene expression in the muscle and central nervous system following intramuscular inoculation of encapsidated or naked poliovirus replicons.
    Jackson CA; Messinger J; Palmer MT; Peduzzi JD; Morrow CD
    Virology; 2003 Sep; 314(1):45-61. PubMed ID: 14517059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Attributable risk of DTP (diphtheria and tetanus toxoids and pertussis vaccine) injection in provoking paralytic poliomyelitis during a large outbreak in Oman.
    Sutter RW; Patriarca PA; Suleiman AJ; Brogan S; Malankar PG; Cochi SL; Al-Ghassani AA; el-Bualy MS
    J Infect Dis; 1992 Mar; 165(3):444-9. PubMed ID: 1538150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surveillance of suspected poliomyelitis in Albania, 1980-1995: suggestion of increased risk of vaccine associated poliomyelitis.
    Diamanti E; Ibrahimi B; Tafaj F; Mezini E; Dodbiba A; Dobi V; Catone S; Genovese D; Simeoni P; Fiore L
    Vaccine; 1998; 16(9-10):940-8. PubMed ID: 9682341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Poliovirus induces apoptosis in the mouse central nervous system.
    Girard S; Couderc T; Destombes J; Thiesson D; Delpeyroux F; Blondel B
    J Virol; 1999 Jul; 73(7):6066-72. PubMed ID: 10364359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.